(1H-pyrazol-1-yl)methanediamine hydrochloride → HCID 178439346, compound
Reaction equation
[NH2:1][CH2:2]/[C:3](/[CH3:29])=[CH:4]/[C:5]1[CH:26]=[C:25]([F:27])[C:8]([O:9][C:10]2[CH:15]=[CH:14][C:13]([S:16]([NH:19][CH2:20][CH2:21][N:22]([CH3:24])[CH3:23])(=[O:18])=[O:17])=[CH:12][CH:11]=2)=[C:7]([F:28])[CH:6]=1.Cl.[N:31]1([CH:36](N)[NH2:37])C=CC=N1>C1COCC1>[F:28][C:7]1[CH:6]=[C:5](/[CH:4]=[C:3](\[CH3:29])/[CH2:2][NH:1][C:36]([NH2:37])=[NH:31])[CH:26]=[C:25]([F:27])[C:8]=1[O:9][C:10]1[CH:15]=[CH:14][C:13]([S:16]([NH:19][CH2:20][CH2:21][N:22]([CH3:24])[CH3:23])(=[O:17])=[O:18])=[CH:12][CH:11]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of (E)-4-(4-(3-amino-2-methylprop-1-enyl)-2,6-difluorophenoxy)-N-(2-(dimethylamino)ethyl)benzenesulfonamide (Intermediate 93.4, 39.3 mg, 0.092 mmol) in dry THF (460 uL, 0.2M) under N2 was added TEA (0.276 mmol, 27.9 mg) and (1H-pyrazol-1-yl)methanediamine hydrochloride (0.102 mmol, 14.9 mg). The resulting solution was stirred for 1 hour, at which point LCMS indicated complete conversion. The solvent was removed and the resulting residue brought up in 1:1 ACN:water and purified by preparative HPLC to give 16.9 mg of the title compound (26%) as a TFA salt. 1H-NMR (400 MHz, CD4OD): δ 7.87 (d, 2H), 7.12 (d, 2H), 7.08 (d, 2H), 3.92 (s, 2H), 3.62 (m, 2H), 3.29 (m, 2H), 3.17 (t, 2H), 2.01 (s, 6H), 1.91 (s, 3H). MS (m/z): 468.12 (M+H)+.
Workup
- customThe solvent was removed
- customwater and purified by preparative HPLC
Sources & evidence
- ORD record
- ord-f1ae7cebc96a4484b4fdef0434cfff50
- Source dataset
- uspto-grants-2013_09
- Patent number
- US08541448B2
Reaction notes
Loading…